A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.
Each year, several medical students work for 12 months as dean’s research fellows. An increase in applications shows more students are interested in learning the fundamental tools of research.
Dr. Jacques Ambrose describes the symptoms and treatments for depersonalization disorder in the wake of recent news about "SNL" cast member Bowen Yang.
Lecanemab, marketed as Leqembi, is the first drug for Alzheimer’s disease to receive approval on the basis of clinically slowing the progression of Alzheimer’s disease.
Through a new cancer drug discovery program, Columbia researchers are working to translate discoveries made in their labs into lifesaving treatments for patients.
